相关实验视频

Updated: Jun 23, 2025

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

血清HLA-G在多发性骨髓瘤血管生成中的影响

Chi Wang¹, Nai-Wen Su^2,3, Kate Hsu^3,4,5

¹Department of Laboratory Medicine, MacKay Memorial Hospital, New Taipei, 25160, Taiwan.

Molecular medicine (Cambridge, Mass.)

|June 14, 2024

概括

可溶性人类白细胞抗原G (sHLA-G) 抑制多发性骨髓瘤 (MM) 的瘤血管生成. 较低的sHLA-G水平与MM复发相关,表明其作为预防疾病复发的治疗点的潜力.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
癌症生物学癌症生物学

背景情况:

多发性骨髓瘤 (MM) 是一种无法治愈的血液癌症,经常复发.
瘤血管生成是与MM复发相关的关键因素.
人类白细胞抗原G (HLA-G) 已知可以抑制血管生成.

研究的目的:

研究可溶性HLA-G (sHLA-G) 在MM复发中的作用.
检查MM中sHLA-G,VEGF和IL-6之间的关系.
探索调节MM中sHLA-G表达的机制.

主要方法:

在57名MM患者的缓解和复发期间测量了sHLA-G,VEGF和IL-6的血清水平.
在体外实验中评估了sHLA-G,VEGF和IL-6之间的相互作用.
异种移植小鼠模型被用来研究在不同氧度和IL-6刺激下sHLA-G表达.

主要成果:

发现HLA-G蛋白降解可以增加血管生成.
可溶性HLA-G在体外直接抑制了血管形成.
在低氧状态下,MM细胞中的HLA-G表达受HIF-1α的调节;当IL-6刺激时,两者都通过PARKIN降解.

结论:

在MM的不同阶段,sHLA-G在血管生成中起着重要作用.
sHLA-G 作为MM的血管生成抑制剂.
sHLA-G可能是旨在预防MM复发的新疗法的一个有价值的目标.

关键词:

血管新生的产生.人类白细胞抗原G 低氧诱导因子-1α.介质素 6 介质素 6 介质素多发性骨髓瘤是一种多发性骨髓瘤.血管内皮生长因子血管内皮生长因子

更多相关视频

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact

Published on: July 17, 2016

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...